Showing 451-460 of 1093 results for "".
- DefenAge Skincare Launches New Patented Skin Regeneration Technologyhttps://modernaesthetics.com/news/defenage-skincare-launches-new-patented-skin-regeneration-technology/2473630/DefenAge Skincare announced a new skin regeneration technology with the acquisition of a new patent using a regenerative approach for skin care and wound healing. The company says the cutting-edge technology is now available for licensing and product development partnerships, presenting an unpara
- Clean Skincare Line Launches Age-Defying Peptide Serumhttps://modernaesthetics.com/news/clean-skincare-line-launches-age-defying-peptide-serum/2473623/Topical Skin, a clean cosmeceutical company, launched a new age-defying peptide serum. The goal of the serum is to combat signs of aging and reveal a youthful complexion. The age-defying peptide serum contains a blend of peptides, including Acetyl Tetrapeptide-5 and Acetyl Hexapep
- Demand for Minimally Invasive Procedures Contributing to Medical Laser Technologies Surgehttps://modernaesthetics.com/news/demand-for-minimally-invasive-procedures-contributing-to-medical-laser-technologies-surge/2473617/The global market for medical laser technologies is forecasted to reach $6.4 billion in 2024, according to research from the Medical Laster Technologies – A Global Market Overview. The report explores the market value from 2020 to 2029. Research found the medical laser techn
- New Skin-Responsive FUE Technique Improves Hair Restoration Results Among Individuals of African Descent,https://modernaesthetics.com/news/new-skin-responsive-fue-technique-improves-hair-restoration-results-among-individuals-of-african-descent/2473468/A new follicular unit excision (FUE) device may improve hair restoration results among individuals of African descent, according to a study in Dermatologic
- Cartessa Aesthetics Introduces Helix by DEKAhttps://modernaesthetics.com/news/cartessa-aesthetics-introduces-helix-by-deka/2473418/Cartessa Aesthetics is rolling out Helix by DEKA, a fractional ablative CO2 and non-ablative technologies in one device. The US is the first market to make HELIX commercially available. HELIX features pulse shape control for CoolPeel treatment and adds a 1570nm fiber lase
- FDA Clears Renuvion APR Handpiece for Coagulation of Subcutaneous Soft Tissues after Liposuction for Body Contouringhttps://modernaesthetics.com/news/fda-clears-renuvion-apr-handpiece-for-coagulation-of-subcutaneous-soft-tissues-after-liposuction-for-body-contouring/2473404/The U.S. Food and Drug Administration (FDA) cleared the Renuvion APR Handpiece for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring. “The Renuvion APR handpiece is the only device to have a 510(k)
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).
- Dermalogica Offers Digital Accreditation Badge for Beauty Proshttps://modernaesthetics.com/news/dermalogica-offers-digital-accreditation-badge-for-beauty-profs/2473391/Dermalogica is launching a new medispa accreditation for professional skin therapists. Launching April 17, 2023, the program aims to raise industry standards and provide more transparency to consumers. Unlike state board requirements that lead to esthetics licensing, the
- BTL Cracks Down on Counterfeit Devices in the U.S.https://modernaesthetics.com/news/btl-cracks-down-on-counterfeit-devices-in-the-us/2473373/BTL is making inroads in its efforts to safeguard medical providers and consumers from counterfeit devices in the United States through legal action and the seizure of illegally imported devices at the border. BTL has filed court documents stating that defendants use and sell knock
- U.S. FDA Clears Renuvion to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissuehttps://modernaesthetics.com/news/fda-clears-of-renuvion-to-coagulate-and-contract-soft-tissues-including-subcutaneous-tissue/2473371/The U.S. Food and Drug Administration (FDA) has cleared the use of the Renuvion APR Handpiece for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. (Soft tissue includes subcutaneous tissue.) “We are pleas